Product Information
LAMOTRIGINE ER 200 MG TABLET is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.6085 per EA under NDC 65162098603. Its NADAC has been published 360 times since Nov 13, 2019.
FDA first approved this application on Nov 30, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Amneal Pharmaceuticals LLCNDC
65162098603
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LAMOTRIGINEApproval Type
Generic (ANDA)
FDA Application
ANDA207497FDA Approved
11/30/2018
TE Code
AB
On Market Since
11/30/2018
Pharmacological Classes
Price Statistics
The NADAC for LAMOTRIGINE ER 200 MG TABLET has been published 360 times since Nov 13, 2019, and over the history we have for it it has declined 79.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6085 per EA |
|---|---|
| All-time high | $3.0472 (Dec 11, 2019) |
| All-time low | $0.4877 (Nov 20, 2024) |
| 52-week high | $0.8174 |
| 52-week low | $0.6085 |
| Median price | $0.9948 |
| Average price | $1.3147 |
| Largest weekly change | -39.7% (Nov 20, 2024) |
| Weeks tracked | 360 |
| Tracking since | Nov 13, 2019 |
Generic Alternatives
The matcher finds 15 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 86% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lamotrigine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LAMOTRIGINE ER 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE ER 200 MG TABLET, manufactured by Amneal Pharmaceuticals LLC, is $0.6085 per EA (NDC 65162098603), effective Sep 30, 2026.
How has the price of LAMOTRIGINE ER 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMOTRIGINE ER 200 MG TABLET has declined 79.7%. It has been tracked across 360 weekly CMS publications since Nov 13, 2019.
What are the highest and lowest recorded NADAC prices for LAMOTRIGINE ER 200 MG TABLET?
Since Nov 13, 2019, the NADAC for LAMOTRIGINE ER 200 MG TABLET has ranged from a low of $0.4877 (Nov 20, 2024) to a high of $3.0472 (Dec 11, 2019), with a median of $0.9948 per EA.
Are there cheaper alternatives to LAMOTRIGINE ER 200 MG TABLET?
Yes. 15 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LAMOTRIGINE 200 MG TABLET, is $0.0825 per EA — about 86% below LAMOTRIGINE ER 200 MG TABLET.
Who manufactures LAMOTRIGINE ER 200 MG TABLET?
LAMOTRIGINE ER 200 MG TABLET (NDC 65162098603) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.